Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
new york blog main
3
×
san diego blog main
3
×
san francisco blog main
san francisco top stories
boston blog main
cancer
ipo
national top stories
new york top stories
raleigh-durham blog main
san diego top stories
san francisco
seattle blog main
seattle top stories
startups
10x genomics
abbvie
acetylon pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ambys medicines
amunix
anirvan ghosh
astellas pharma
astrazeneca
becton dickinson
biogen
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cell therapy
What
deal
3
×
help
make
medicines
acquisitions
adding
aiming
aims
ambys
announced
big
bio
biotech
ceo
collabs
company
control
covid
daniel
deadly
debuted
decisions
diagnostic
diagnostics
diseases
expand
fold
formed
future
gilead
gilead’s
introduce
ipo
launch
liver
month
nanostring
new
o’day
physicians
Language
unset
Current search:
deal
×
" new york blog main "
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
